Ultrafast photochemistry produces superbright short-wave infrared dots for low-dose in vivo imaging by Santos, Harrisson D. A. et al.
ARTICLE
Ultrafast photochemistry produces superbright
short-wave infrared dots for low-dose in vivo
imaging
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Carlos Jacinto2, Blanca del Rosal11, Ajoy K. Kar8, Jorge Rubio-Retama 3,4✉ & Daniel Jaque 1,4✉
Optical probes operating in the second near-infrared window (NIR-II, 1,000-1,700 nm), where
tissues are highly transparent, have expanded the applicability of fluorescence in the bio-
medical field. NIR-II fluorescence enables deep-tissue imaging with micrometric resolution in
animal models, but is limited by the low brightness of NIR-II probes, which prevents imaging
at low excitation intensities and fluorophore concentrations. Here, we present a new gen-
eration of probes (Ag2S superdots) derived from chemically synthesized Ag2S dots, on which
a protective shell is grown by femtosecond laser irradiation. This shell reduces the structural
defects, causing an 80-fold enhancement of the quantum yield. PEGylated Ag2S superdots
enable deep-tissue in vivo imaging at low excitation intensities (<10 mW cm−2) and doses
(<0.5 mg kg−1), emerging as unrivaled contrast agents for NIR-II preclinical bioimaging.
These results establish an approach for developing superbright NIR-II contrast agents based
on the synergy between chemical synthesis and ultrafast laser processing.
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Semiconductor nanocrystals emerged almost two decadesago as novel fluorescent contrast agents capable of over-coming the intrinsic limitations of traditional fluorescent
biomarkers (dyes and fluorescent proteins)1,2. The demonstration
of the ability of these nanocrystals to generate high-contrast
images at the cellular level was a major milestone in biophotonics
and promoted further research into these materials. Optimizing
their chemical stability, biocompatibility, and brightness was the
major focus of the subsequent investigation3,4. That resulted in
the development of core/shell architectures, which constituted the
second generation of semiconductor nanocrystals5,6. These pro-
duced unparalleled results in cell imaging7, but failed to enable
deep-tissue in vivo imaging as biological tissues are efficient
absorbers and scatterers of visible light. This limitation was
overcome by the development of a third generation of semi-
conductor nanocrystals, emitting in the second near-infrared
window (NIR-II, 1000–1700 nm)8. In this spectral range, the
absorption and scattering coefficients of biological tissues are
reduced to a minimum, allowing high-contrast, high-resolution
in vivo imaging at large (>1 cm) tissue depths9. NIR-II fluorescent
materials have changed the game in preclinical imaging10,11,
enabling high-resolution anatomical imaging12,13, tumor
detection14,15, biosensing16, brain vasculature mapping17,18,
image-guided genome editing19 and surgery20,21, and dynamic
tracking of metabolic processes22. NIR-II-emitting Ag2S nano-
crystals do not contain highly toxic heavy metal ions, unlike other
nanoprobes operating in this spectral range, minimizing bio-
compatibility concerns and making them one of the most pro-
mising systems among all currently reported NIR-II
fluorophores23,24. Their properties have been exploited for mul-
tiple applications, including subcutaneous and transcranial ther-
mometry25, tumor theranostics via photoacoustic imaging and
photothermal therapy26, early tumor diagnosis27 and dynamic
imaging of the heart28 and the cardiovascular system29–31.
To enhance the potential of Ag2S dots as NIR-II contrast agents,
their properties need substantial improving to enable deep-tissue
imaging at irradiation intensities well below the established safety
threshold. Currently available Ag2S dots are limited by their low
fluorescence brightness, which is a result of their low quantum
yield (QY < 1%) and short fluorescence lifetime (<100 ns)32. These
features have been attributed to the presence of surface and
structural defects and to the dot–solvent interactions that favor
electronic deexcitation via non-radiative pathways33. Furthermore,
the high redox potential of silver ions and the high temperatures
required for Ag2S dots synthesis lead to the simultaneous for-
mation of metallic silver nanoparticles (NPs) that could also
reduce the overall brightness due to plasmon coupling events34.
Currently available chemical synthesis routes have failed to avoid
these non-radiative channels in Ag2S dots. Therefore, developing
alternative approaches is essential to overcome this barrier.
In this work, we present a novel methodology that permits an
80-fold increment in the QY of Ag2S dots. The process is based
on the irradiation of chloroform-dispersed Ag2S dots with fem-
tosecond laser pulses, which leads to the formation of a protective
AgCl shell. This reduces the surface traps while minimizing dot-
to-medium energy transfer via non-radiative events. The bright-
ness of the NPs generated in this process is superior to that of all
other currently available NIR-II contrast agents. Their improved
performance enables in vivo whole body imaging, blood vessel
visualization, and biodistribution tracking at ultra-low excitation
intensities.
Results
Preparation and characterization of Ag2S superdots. We fab-
ricated Ag2S superdots by irradiating a dispersion of chemically
synthesized Ag/Ag2S heterodimers (hereafter Ag2S dots) in
CHCl3 with femtosecond laser pulses. The chemical synthesis
route we used (described in Methods) yields silver NPs as a side
product (see Supplementary Fig. 1). The presence of these NPs is
due to the high redox potential of silver ions at the reaction
temperature35. To eliminate them, a 1 mgmL−1 CHCl3 disper-
sion of Ag2S dots was irradiated with a Ti:Sapphire femtosecond
laser operating at 808 nm (see details in Methods). Laser pulses
trigger the transformation of Ag NPs into AgCl particles, which
are colloidally unstable and easy to remove (see Supplementary
Fig. 2).
Fig. 1 shows the morphological and compositional analysis of
the Ag2S dots before and after ultrafast laser irradiation. Fig. 1a
depicts a high-angle annular dark-field scanning transmission
electron microscopy (HAADF-STEM) image of the as-
synthesized Ag2S dots. They present an elliptical morphology
with an average size of 9.5 ± 1.0 nm (see Supplementary Fig. 3).
The NPs present an eccentrically located, electron-dense core
embedded in a matrix of lower electron density. The high-
resolution STEM of a typical particle reveals a crystalline
structure (Fig. 1b), with lattice fringes d−104= 2.37 Å and, in
the electron-dense core, d111= 2.30 Å. These well match mono-
clinic Ag2S (JCPDS No. 14-0072) and cubic Ag (JCPDS 04-0783),
respectively. The less electron-dense area in Fig. 1b is postulated
to be Ag2S, as Ag2S has a lower density (7.2 g cm−3) than Ag
(10.505 g cm−3). Energy-dispersive X-ray spectroscopy (EDS)
analysis, shown in Fig. 1c–e, supports this conclusion. While the
NP core is rich in Ag, S is mainly located in the outer part of the
NPs. This anisotropic distribution of elements is depicted in the
net X-ray intensity profiles shown in Fig. 1g as obtained from the
magnified STEM micrograph shown in Fig. 1f. In Fig. 1g, we can
observe that the maximum of the X-ray intensity assigned Ag and
S atoms arises, respectively, from the electron-dense core and the
outer area. The elemental analysis of a Ag2S dot shows a Ag:S
ratio of 74:26. All these results support the presence of a metallic
Ag core within the Ag2S matrix.
After ultrafast illumination with 50 fs pulses for 90 min (9W
cm−2), the average diameter of the NPs increased from 9.5 ± 1.0
to 12.3 ± 1.0 nm, while the size of the metallic Ag core remained
constant at around 5.1 nm (see Fig. 1h and Supplementary Fig. 3).
High-resolution STEM of a representative Ag2S dot after ultrafast
laser irradiation (Fig. 1i) reveals, again, two well-differentiated
crystalline regions. An electron-dense core, with lattice fringe of
d111= 2.30 Å that agrees with metallic Ag is embedded in a
matrix with a lattice fringe of d110= 2.50 Å, corresponding to
Ag2S. The presence of a 1-nm-thick shell around the NPs can also
be observed in this figure. Based on the analysis of the
corresponding crystal lattices, the conjunction interfaces between
the metallic and the semiconductor part consist of the (110) plane
of Ag2S and (111) of Ag, with a lattice mismatch of 8%. EDS
images (Fig. 1j–m) revealed that the resulting NPs are composed
of Ag and S with an identical distribution as that observed in the
as-synthesized NPs. Further, EDS analysis indicated the presence
of Cl atoms distributed throughout the laser-irradiated Ag2S dots
(Fig. 1l). This stems from the formation of a AgCl shell. The
presence of this shell is also evidenced in the net X-ray intensity
profiles shown in Fig. 1o, obtained from the magnified STEM
micrograph shown in Fig. 1n. The elemental analysis of a laser-
treated Ag2S dot shows a Ag:S:Cl ratio of 69:24:7. Again, the
excess of Ag would indicate the conservation of the silver-rich
core characteristic of the Ag2S dots. Further chemical and
structural characterization of the samples, including X-ray
diffraction, X-ray absorption near edge structure (XANES),
EDS, and HAADF-STEM data of both Ag2S dots and superdots
is provided in Supplementary Figs. 4 and 5. These additional
data support the conclusions extracted from Fig. 1 that the
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as-synthesized dots are composed of two phases, a monoclinic
Ag2S phase and a cubic Ag phase. When these NPs are irradiated
with an ultrafast laser, their chemical composition and structure
change. The resulting NPs exhibit a new AgCl phase forming a
thin outer shell, as observed in Fig. 1i.
Optical transformation of Ag2S dots into superdots. The
structural changes induced in the Ag2S dots by ultrafast laser
pulses, summarized in Fig. 1, are accompanied by a dramatic
change in their optical properties. This change is visible to the
naked eye, as seen in Fig. 2a, which contains the optical images of
a colloidal dispersion of as Ag2S dots in CHCl3 before and after
ultrafast laser irradiation (50 fs, 90 min, 9W cm−2). The disper-
sion changes color as a result of the ultrafast laser irradiation,
becoming progressively more transparent (see Supplementary
Fig. 6). Ultrafast laser irradiation reduces the absorbance of the
sample in the 400–800 nm range by 35%, as seen in Fig. 2b. This
reduction occurs progressively during ultrafast laser irradiation,
as shown in Supplementary Fig. 6. The absorption spectrum of
the as-synthesized Ag2S dots presents a shoulder around 400 nm,
which corresponds to the plasmonic band of sub-100-nm Ag
NPs36. This shoulder is no longer present after ultrafast laser
irradiation. Besides modulating the optical absorption, ultrafast
laser irradiation enhances the fluorescence brightness of the Ag2S
dots, as shown in the NIR-II fluorescence images in Fig. 2c. These
correspond to a colloidal dispersion of Ag2S dots before and after
ultrafast laser irradiation (50 fs, 90 min, 9W cm−2). The emission
of the as-synthesized Ag2S dots is barely detectable with our NIR-
II imaging system, in contrast to the high signal observed after the
irradiation process. This enhancement in the NIR-II brightness
occurs progressively during ultrafast irradiation, as seen in
Fig. 2d, which shows the time evolution of the NIR-II emission of
Ag2S dots during the process. The shape of the emission spec-
trum, as seen in the inset in Fig. 2d, remains virtually unchanged.
This result indicates that the chemical nature of the fluorophore
does not change upon irradiation. Fig. 2e shows the fluorescence
QY of different colloidal dispersions of Ag2S dots in CHCl3 after
different durations of ultrafast laser irradiation (50 fs, 9W cm−2).
Supplementary Fig. 7 includes some representative excitation and
emission spectra used for QY calculations. The QY increases
monotonously with the irradiation time for treatment durations
shorter than 50 min, while longer irradiations do not lead to any
further increase. The QY of as-synthesized Ag2S dots increases
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Fig. 1 Tuning structural and chemical properties through ultrafast laser irradiation. a HAADF-STEM micrograph of the as-synthesized Ag2S dots. Scale
bar is 10 nm. b High-resolution STEM of as-synthetized dots showing lattice fringes d111 and d−104 of cubic Ag and monoclinic Ag2S, respectively. 2D EDS
mapping of the spatial distribution of Ag (c), S (d), and Ag+S (e). fMagnified STEM micrograph of two Ag2S dots. g Net X-ray intensity profiles extracted
from the green arrow marked in f. Note how the Ag/S ratio increases at the edges of the dots, which coincides with the electro-dense area. The inset
shows a model Ag2S dot. h HAADF-STEM micrograph of Ag2S dots after ultrafast laser irradiation with 50 fs laser pulses for 90min at a power density of
9W cm−2. Scale bar is 10 nm. i High-resolution STEM of an ultrafast laser-irradiated Ag2S dot showing lattice fringes d111 and d110 of cubic Ag and
monoclinic Ag2S, respectively. Note the presence of a shell marked with a blue bracket around the nanoparticle. 2D EDS mapping of the spatial distribution
of Ag (j), S (k), Cl (l), and Ag+S+ Cl (m) of an ultrafast laser-irradiated Ag2S dot. nMagnified STEM micrograph of an ultrafast laser-irradiated Ag2S dot.
o Net X-ray intensity profiles extracted from the green arrow marked in image (n), where we can observe the presence of Ag, S, and Cl. The inset in
o shows a schematic representation of a single Ag2S dot after ultrafast laser irradiation.
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from 0.13 to 10.7% in a 50-min-long irradiation with 50 fs pulses.
This constitutes an 80-fold enhancement, validating our referring
to the laser-irradiated Ag2S dots as superdots. This QY
enhancement is accompanied by a substantial increase in the
fluorescence lifetime from 200 ns up to 2.1 μs, as shown in Fig. 2f
(see Supplementary Fig. 6 for the decay curves). This lifetime
increase follows the same trend with the irradiation time observed
for the QY in Fig. 2e and is independent of the dot concentration
in the 0.1–1 mgmL−1 range, as shown in Supplementary Fig. 8.
These results rule out any possible contribution of fluorescence
self-absorption to our lifetime measurements.
Mechanism of dot-to-superdot transformation. The dot-to-
superdot transformation induced by ultrafast laser irradiation
depends critically on multiple experimental variables. Fig. 3a shows
the time evolution of the NIR-II fluorescence intensity generated
by a colloidal dispersion of dots in CHCl3 during ultrafast laser
irradiation at different irradiation power densities for irradiation
times up to 100min. The curves in Fig. 3a were obtained for
constant pulse duration (50 fs), repetition rate (1 kHz), and average
power (0.6W). For irradiation power densities below 3W cm−2,
which seems to be a threshold value, there is no apparent
improvement in the luminescence properties. For irradiation
power densities between 3 and 8W cm−2, the NIR-II fluorescence
intensity increases with the irradiation time. In this range of power
densities, the slope of the intensity vs. time curve (η= dI/dt)
strongly depends on the irradiation pulse energy (Ep). In fact, η is
proportional to E2p , which suggests that the dot-to-superdot
transformation is triggered by a two-photon absorption process
(see Supplementary Note 1 and Supplementary Fig. 9). For irra-
diation power densities between 8 and 9W cm−2, the NIR-II
fluorescence intensity increases with irradiation time until a stable
value is reached. Finally, irradiation at or above 10W cm−2 leads
to a decrease in the emitted intensity for long irradiation times that
may be attributed to sample degradation. This effect is highlighted
for irradiation power densities close to 100W cm−2. Under these
conditions, an initial increase in the emission intensity is followed
by an abrupt reduction, rendering a nonluminescent and com-
pletely transparent dispersion. Plotting the fluorescence intensity of
the irradiated solution as a function of the irradiation power
density evidences the existence of an optimum irradiation power
density close to 9W cm−2 (see Supplementary Fig. 10).
Fig. 3b demonstrates that ultrafast laser-induced dot-to-
superdot transformation only occurs when the as-synthesized
Ag2S dots are dispersed in CHCl3. When they are dispersed in
water, toluene, or hexane, pulsed irradiation leads to a decrease
in their NIR-II fluorescence that can be attributed to laser-
induced thermal loading (see Supplementary Note 2 and
Supplementary Fig. 11). The presence of silver is also critical
for the dot-to-superdot transformation. We corroborated this
fact by analysing the effect of ultrafast laser irradiation in a
Ag2S dot dispersion free of Ag NPs (see Methods and
Supplementary Fig. 12 for details). Ultrafast laser irradiation
of these dots does not improve their fluorescence, as evidenced
in Fig. 3c. Thus, ultrafast laser-driven dot-to-superdot trans-
formation requires not only the presence of CHCl3 but also of
Ag NPs in the dispersion.
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Fig. 2 Optical transformation of Ag2S dots into superdots. a Optical images, b UV-VIS-NIR extinction spectra, and c NIR-II fluorescence images of a
colloidal dispersion of Ag2S dots in CHCl3 before and after ultrafast laser irradiation (50 fs, 90min, 9W cm−2). For the acquisition of NIR-II fluorescence
images, the dispersions were optically excited with an 808 nm continuous wave laser diode (100mWcm−2). d NIR-II emission spectra generated by a
colloidal suspension of dots in CHCl3 during a 90-min-long ultrafast laser irradiation. The inset shows the normalized emission spectra of the sample
before and after the laser irradiation. e Fluorescence quantum yield and f fluorescence lifetime of Ag2S dots in CHCl3 after being subjected to ultrafast laser
irradiations processes of different durations. The error bars in e were calculated taking into account the equipment uncertainty that was determined from
the statistical analysis of five measurements. In f, each measurement was repeated five times and the error bars are the standard error of the mean of each
series of measurements. Repetitive measurements to calculate both mean and error were performed on the same sample. The small relative uncertainties
in QY (2%) make the error bars too small to be visualized in e. In f, the error bars correspond to the standard error of the mean after measuring and
analysing 10 decay curves for each sample. In e and f, the squares correspond to the experimental data and the red lines are guides for the eyes.
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Moreover, the dynamics of the dot-to-superdot transformation
depends critically on the duration of the laser pulses. Fig. 3d
shows the time evolution of the NIR-II intensity emitted by a
dispersion of Ag2S dots in CHCl3 during irradiation with laser
pulses of different durations and identical power (0.6W) and
power density (9W cm−2). The efficiency of the dot-to-superdot
transformation, estimated from the magnitude of the enhance-
ment in the NIR-II emission, decreases for longer pulse durations.
Irradiation with a continuous wave laser does not improve the
NIR-II fluorescence brightness, indicating that no dot-to-
superdot transformation occurs.
The experimental results shown in Figs. 1–3 allow us to provide
a plausible explanation for the dot-to-superdot transformation.
This is schematically shown in Fig. 3e. Due to the synthesis route
used here, the as-prepared dispersions of Ag2S dots also contain
Ag NPs. The plasmon resonance of these Ag particles is
responsible for the extinction peak observed at around 400 nm
(see Fig. 2b). When excited with 808 nm ultrafast pulses, two-
photon absorption by Ag NPs induces a high free electron density
that results in the Coulomb explosion of the Ag NPs (step 1 in
Fig. 3e)37. The key role of multiphoton excitation is supported by
the requirement of ultrafast laser pulses that ensure high photon
densities. These allow for sequential absorption through virtual
states of Ag NPs38. The participation of two 808 nm photons in
this process is further supported by the experimental data in
Supplementary Fig. 9. The Coulomb explosion of Ag NPs leads to
an increment in the concentration of highly reactive Ag+ in the
solution, which react with CHCl3 yielding silver chloride (AgCl,
step 2 in Fig. 3e). The laser-generated AgCl molecules interact
with the surface of the Ag2S dots, where a protective a AgCl shell
is formed (steps 3 and 4 in Fig. 3e). Therefore, after ultrafast laser
irradiation, the low‐bandgap semiconductor Ag2S (0.9 eV) is
coated with an inorganic shell of higher‐bandgap AgCl (5.13 eV)
several monolayers thick, as seen in Fig. 1i39. This protective shell
strongly reduces the non-radiative transitions that involve the
vibronic activation of solvent CHCl3 molecules and prevents the
formation of shallow or deep midgap states as surface traps that
would provide non-radiative deexcitation pathways. The reduction
in the non-radiative decay probabilities caused by this protective
shell simultaneously explains the increment in the NIR-II QY and
the fluorescence lifetime. The decrease in the non-radiative decay
probability is also evidenced by a reduction in the light-to-heat
conversion efficiency when the dot-to-superdot transformation
takes place (see Supplementary Fig. 13 and Supplementary
Note 3). Both dots and superdots can be damaged under excessive
irradiation doses, explaining why at high irradiation power
densities the initial enhancement in NIR-II luminescence is
followed by a nonreversible quenching (see Fig. 3a). An arising
question is why the multiphoton excitation and subsequent
Coulomb explosion only occur in the Ag NPs and not in the Ag
cores within the Ag2S dots. A plausible explanation is that Ag
cores have no plasmonic resonance that can be excited by 808 nm
fs laser pulses due to being surrounded by Ag2S. The very different
dielectric constants/refractive indices of CHCl3 and Ag2S could be
behind this effect, since the spectral location of the plasmon
resonance of Ag NPs strongly depends on the dielectric constant/
refractive index of the surrounding medium40. The absence of
multiphoton excitation of the Ag core would prevent its Coulomb
explosion, required for the formation of the AgCl shell41.
In vivo NIR-II imaging with Ag2S superdots. To test the
potential application of Ag2S superdots for in vivo NIR-II
imaging, we transferred them from their original solvent
(CHCl3) to phosphate buffer saline (PBS) by means of a ligand
exchange procedure described in Methods. The adhesion of
hydrophilic and bifunctional HS-PEG-COOH ligands on the
surface of Ag2S superdots makes them stable in PBS with no
signs of precipitation for at least 12 months. The average
hydrodynamic diameter and Z-potential after ligand exchange
are 22 nm, and −25 mV, respectively. PEG coating and dis-
persion in PBS does not significantly reduce the fluorescence
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decay time of Ag2S superdots, which is close to 2 μs (see
Fig. 4a). The fact that Ag2S superdots show the same decay time
in CHCl3 and PBS reveals the effectiveness of the AgCl pro-
tective shell against the appearance of multiphonon relaxation
events favored by the vibration modes of water molecules. This,
in turn, results in identical QY values (≈10%) in both solvents.
Fig. 4a also includes, for the sake of comparison, the
fluorescence decay curve obtained from commercially available
(Sinano Corp. China) PEG-coated Ag2S dots dispersed in PBS.
These show a fluorescence lifetime of 53 ns, about 40 times
shorter than that of PBS-dispersed PEG-coated Ag2S superdots.
Such a long fluorescence lifetime and high QY suggests the
potential application of PEGylated Ag2S superdots for high-
contrast, low-dose NIR-II in vivo imaging.
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To evaluate the performance of Ag2S superdots in in vivo
imaging, we benchmarked them against other well-established
NIR-II fluorescent probes: commercial Ag2S dots, neodymium-
doped nanocrystals (LaF3:Nd3+), and single-walled carbon
nanotubes (SWNTs)42–44. FDA-approved indocyanine green
was not included in this comparison as preliminary experiments
revealed the poor spectral overlap between its emission tail and
the spectral response of our NIR-II imaging system (see
Supplementary Figs. 14 and 15)45,46. For our comparative study,
we used four different mice that were subcutaneously injected
with 100 μL of a PBS solution containing, in each case, Ag2S
superdots, Ag2S dots, LaF3:Nd3+, and SWNTs. The NP
concentration was set in all cases to 1.5 mg mL−1, corresponding
to a total injected NP dose of ≈5 mg kg−1. Fig. 4b shows the
in vivo NIR-II fluorescence images obtained in each case for 808
nm illumination power densities ranging from 227 down to 0.3
mW cm−2. These results indicate that Ag2S superdots outperform
all other NIR-II fluorescent probes evaluated here from a
brightness standpoint (see Supplementary Table 1). We con-
sidered the possibility of experimental error in these results due to
individual variations in the thickness of the mouse skin. However,
this would only account for 20% of the total variation in the
transmitted fluorescence (±80 μm over a 400 μm layer of skin, see
Supplementary Note 4). These variations are negligible compared
with the dramatic difference in the emission intensity observed
experimentally between the Ag2S superdots and the rest of the
evaluated fluorescent probes. The superior brightness of the
superdots enables the acquisition of fluorescence images with
sufficient contrast even at the ultra-low irradiation power density
of 0.3 mW cm−2, where no fluorescence from any of the other
three tested NIR-II probes could be registered. This not only
allows in vivo imaging with cost-effective excitation sources but
also ensures a negligible thermal loading during image acquisition
(see Supplementary Fig. 16)38. The superior contrast achieved
imaging with Ag2S superdots is quantified in Fig. 4c, which shows
the power density dependence of the signal-to-noise ratio (SNR)
calculated from the fluorescence images in Fig. 4b. From Fig. 4c,
we conclude that the brightness improvement achieved during
ultrafast laser irradiation reduces the minimum illumination
density that can be used for in vivo imaging by almost two orders
of magnitude. This enhancement is also evident when comparing
the illumination conditions used in this work to those reported
previously for Ag2S dots, SWNTs, and lanthanide-doped
nanocrystals (see Supplementary Table 2).
The data in Fig. 4c correspond to the analysis of in vivo images
of subcutaneous injections. To provide a realistic figure of the
minimum power density required for in vivo imaging, we
performed similar experiments for intravenously injected Ag2S
superdots. Injection volume and concentration were set to 100 μL
and 0.15 mgmL−1, respectively. Fig. 4d shows the in vivo
fluorescence images for three different excitation power densities
obtained 30min after intravenous injection of a dispersion of Ag2S
superdots. At this time point, the superdots had accumulated
mostly in the liver and the spleen. Fig. 4e shows the linear
dependence of the SNR with the power density, indicating that
even at a very low excitation intensity (10mW cm−2) the SNR is
above 10 dB. This is a major improvement with respect to the
intensities required for in vivo imaging with Ag2S dots (see
Supplementary Table 2), which are typically above 100mW cm−2.
The high brightness of Ag2S superdots also allows imaging at large
depths (>1 cm) into tissues (see Supplementary Note 5 and
Supplementary Fig. 17).
Ag2S superdots enable improved in vivo visualization of blood
vessels, as shown in Fig. 4f–j. The images in Fig. 4f–h correspond
to the left hind limbs of two mice after intravenous injection of
either Ag2S dots or superdots (see Methods). Injection volume
and concentration were set to 100 μL and 0.15 mgmL−1,
respectively. Fig. 4f shows the magnified luminescence images
of the limb immediately before (top) and 15 s after injection
(bottom). Although the preinjection background (caused by
tissue autofluorescence) was similar in both cases, the image
contrast after injection is substantially higher after injection of
superdots (right) than in the case of dots (left). We quantified the
improvement in image contrast by calculating the signal-to-
background ratio for both sets of images. This was done by
subtracting the background from the overall emission to obtain
net signal images (Fig. 4g), which were also divided by the
background to calculate the signal-to-background ratios (Fig. 4h).
Both the net signal (ISG− IBG, Fig. 4i) and the signal-to-
background (ISG/IBG, Fig. 4j) line profiles along the saphenous
artery (dashed lines in Fig. 4g, h), indicated a superior
performance of the Ag2S superdots as compared with dots. The
pixel profiles in Fig. 4i, j indicate that Ag2S superdots improve the
net signal by 60% and the signal-to-background ratio by 90%
when compared with conventional Ag2S dots. Further discussion
on the NIR-II images, focusing on the relative quality of the ones
presented here to those previously reported by other
groups15,16,18,29,31,47, is included in Supplementary Note 6,
Supplementary Fig. 18 and Supplementary Table 3.
Ag2S superdots also outperform conventional Ag2S dots at in vivo
video rate NIR-II fluorescence imaging. Fig. 5a shows the NIR-II
images obtained at different times after intravenous administration
of PEG-coated Ag2S superdots (100 μL, 0.15mgmL−1). The total
dose (15 μg, ~0.5mg kg−1) is more than one order of magnitude
smaller than the administered dose (6.6mg kg−1) reported for NIR-
II video rate recording with Ag2S dots29. The use of low
administration doses for in vivo imaging is beneficial for different
reasons. First, to develop a cost-effective probe for NIR-II in vivo
imaging, the amount of material required to achieve high contrast
in vivo images should be reduced. Low administration doses
minimize potential toxicity of the probe. Further, Ag2S superdots
show some photothermal effect that requires low administration
doses and illumination intensities to prevent undesirable heating
during in vivo imaging. For the conditions used in this work,
Fig. 4 In vivo brightness of Ag2S superdots: a comparison with their competitors. a NIR-II fluorescence decay curves of PEG-coated Ag2S dots (provided
by Sinano Corp., China) and Ag2S superdots, both dispersed in PBS. b NIR-II fluorescence images of a group of four mice subcutaneously injected with
colloidal aqueous dispersions containing Ag2S superdots, commercial Ag2S dots, SWNTs, and LaF3:Nd NPs. The same NP volume (100 µL) and
concentration (1.5 mgmL−1) were injected in all cases. The different images for same optical probe correspond to different 808 nm illumination power
densities. c Signal-to-noise ratio (SNR) as a function of power density quantified from the analysis of images in b for the four NIR-II nanoprobes evaluated.
d Fluorescence images of Ag2S superdots accumulated in the liver obtained at three different 808 nm excitation power densities. e Power density
dependence of SNR calculated from in vivo NIR-II fluorescence images at different excitation power densities. f NIR-II fluorescence images of the left hind
limbs of two mice immediately before (top) and 15 s after (bottom) of an intravenous injection of Ag2S dots (left) or superdots (right). g Net intensity
images obtained from subtracting the background images (top row in f) from the signal images (bottom row in f). h Signal-to-background images obtained
by dividing the signal intensity images (bottom row in f) by the background images (top row in f). Scale bars in f, g, and h are 2mm. i Net intensity and
j signal-to-background ratio obtained along a line profile across the saphenous artery (indicated as dashed white lines in g and h).
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there is negligible thermal loading due to the photothermal
conversion of Ag2S superdots (see Supplementary Fig. 19). The
images shown in Fig. 5a were obtained under 808 nm excitation
at 10 mW cm−2, which is one order of magnitude lower than the
illumination power density reported for NIR-II video recording
using SWNTs (140 mW cm−2)43. The illumination power density
here used is also much lower than the safety threshold at this
wavelength (329 mW cm−2) established by the International
Commission on Non-ionizing Radiation Protection (ANSI
Z136.1-2000)48. NIR-II video recording enabled us to track the
in vivo biodistribution of our Ag2S superdots. The time evolution
of the NIR-II fluorescence intensity generated by the Ag2S
superdots at the liver, spleen, heart, and femoral artery after
intravenous injection is shown in Fig. 5b. During the first 3 min
after injection, the PEG-coated superdots were circulating and
gathering in the liver, spleen, and heart. The fluorescence signal
observed at the femoral artery is assigned to the presence of Ag2S
superdots in the bloodstream. Fitting this curve to a first-order
exponential, we estimate a blood half-life close to 20 min for the
Ag2S superdots. As seen in Fig. 5a, b, most of the superdots have
been uptaken by the liver and spleen after 30 min. This is
supported by ex vivo NIR-II images taken 100 min after injection
(Fig. 5c). The accumulation of NPs in the liver and spleen has
been widely reported and is related to filtration mechanisms
promoted by the reticuloendothelial system49.
To evaluate the in vivo biocompatibility of our Ag2S superdots,
we analysed the time evolution of weight, food intake, and body
temperature of four CD1 mice for 2 weeks after intravenous
administration of Ag2S superdots dispersed in PBS. The injected
dose (150 μg, equivalent to 5mg kg−1) is one order of magnitude
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Fig. 5 In vivo time-resolved imaging with Ag2S superdots. a NIR-II fluorescence images obtained at different times after intravenous injection of Ag2S
superdots dispersed in PBS (100 µL, 0.15 mgmL−1). b Time evolution of the fluorescence intensity at the liver, spleen, heart, and femoral artery after
intravenous injection of Ag2S superdots. c NIR-II ex vivo fluorescence and optical images of the liver, spleen, heart, and lungs obtained from a mouse
euthanized 100min after intravenous injection of Ag2S superdots. Time evolution of daily food intake (d), weight (e), and body temperature (f) of four CD1
mice after intravenous injection of 300 μL of a dispersion of Ag2S superdots in PBS (0.5 mgmL−1, total dose of 150 μg). The results obtained from a control
group intravenously injected with 300 μL of PBS are included for comparison. Serum concentration (g) of hepatic enzymes (g, h and i) for mice
intravenously injected with Ag2S superdots and control mice as obtained 1 and 28 days after injection. Serum concentration of creatinine (j) and bilirubin
(k) corresponding to mice subjected to an intravenous injection of Ag2S superdots and control mice as obtained 1 and 28 days after injection. (n= 3 for
each group). The error bars correspond to the standard error of the mean (±SEM).
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above that used for NIR-II in vivo video recording. Four additional
mice were injected with 300 μL of PBS and used as a control.
Experimental data included in Fig. 5d–f reveal that, even at such
relatively high administration doses, there are no relevant differences
between both groups. These findings are consistent with the
reported low toxicity of conventional Ag2S dots and with the already
demonstrated ability of AgCl coatings to minimize NP
cytotoxicity50,51. To further test the long-term biocompatibility of
Ag2S superdots, we performed a 28-day subchronic toxicological
experiment and histological analyses, as detailed in the Supplemen-
tary Methods. Supplementary Figs. 20 and 21 show the time course
of ALT, ALP and AST hepatic enzymes, creatinine and bilirubin for
mice injected with Ag2S superdots (100 μL, 0.15mgmL−1). The
serum concentrations of all biomarkers lie within healthy ranges.
The values obtained 1 and 28 days after injection are shown in
Fig. 5g–k both for mice intravenously injected with Ag2S superdots
and for control mice. The hepatic enzymes show a discrete though
not relevant increase at acute time points (24 h), while creatinine
and bilirubin remain unaffected. Twenty-eight days after injection,
the levels of all five metabolites are comparable between both
groups. A more complete discussion of the time-course evolution of
all the biomarkers is included in Supplementary Note 7. These
results suggest a low in vivo toxicity for the Ag2S superdots, which is
consistent with the previously reported good biocompatibility of
Ag2S dots41. This is further supported by the low cytotoxicity of
Ag2S superdots (see Supplementary Fig. 22) and in histological
assays (Supplementary Fig. 23). This is a promising result, although
it is important to remark that the clinical translation of Ag2S
superdots requires further toxicity experiments including studies of
the maximum tolerated dose, the clearance pathways and the effect
of Ag2S superdots on physiology, metabolism, behavior, and
cognition. Thus, such translation is not immediate.
Discussion
Although Ag2S dots have shown excellent properties as NIR-II
optical probes their potential use in preclinical applications is limited
by their low brightness. Traditional synthesis routes lead to Ag2S
dots with QY typically below 1%. Femtosecond laser pulses can
enhance this QY by more than one order of magnitude, up to values
above 10% (Fig. 2e), without affecting the spectral shape of the
broadband emission centered at 1200 nm (Fig. 2d).
The dot-to-superdot transformation triggered by femtosecond
laser pulses is strongly dependent on the experimental conditions. It
requires the presence of silver NPs and chloroform molecules
(Fig. 3b, c). Pulse widths longer than 100 fs lead to slow and inef-
ficient dot-to-superdot transformation (Fig. 3d). We concluded that
dot-to-superdot transformation is a sequential process (Fig. 3e): (i)
femtosecond laser pulses induce the Coulomb explosion of silver
NPs, (ii) silver atoms react with solvent molecules, and (iii) a pro-
tective shell of AgCl surrounds Ag2S dots. This protective shell
(evidenced by electron microscopy, Fig. 1) drastically reduces
surface-related non-radiative processes and leads to an increased
brightness and a longer fluorescence lifetime (Fig. 2f).
In vivo NIR-II imaging experiments demonstrated the ability of
Ag2S superdots for low-dose (administration and irradiation) pre-
clinical imaging (Fig. 4b, c). We demonstrated how the optimization
of the optical properties caused by femtosecond laser pulses
improves both contrast and resolution of deep tissue in vivo images
(Fig. 4g, h). An array of in vitro toxicity, biochemical and histolo-
gical assays suggested a low toxicity for the Ag2S superdots (Fig. 5).
Our discovery, the ability of ultrafast laser pulses to improve
the luminescence properties of NPs, also stimulates the devel-
opment of new synthesis procedures that could benefit from the
synergy between traditional chemical routes and light-matter
interaction processes.
Methods
Chemical reagents. Ethanol absolute, n-hexane (95%), Silver nitrate (99%), L-
Cysteine (96%), sodium diethyldithiocarbamate (DDTC) (ACS reagent grade),
CHCl3 (99.6%), HS-PEG-COOH (2100 g mol−1), and PBS tablets were purchased
from Sigma-Aldrich (Germany) and used as received.
Synthesis of Ag2S dots. Ag2S dots were prepared as follows: 3 mmol of silver
nitrate was poured into a round bottom flask containing 10 mL of octadecylamine
at 160 °C under gentle stirring and N2 atmosphere. After 10 min, the mixture
acquired a metallic blue color. At this stage, 1.5 mmol of L-cysteine was added to
the mixture as sulfur source. As result, the color of the mixture turned from blue to
black indicating the formation of the heterodimer (30 min). Then, the sample was
cooled down and the product of the reaction was dispersed in 40 mL of CHCl3.
This dispersion was centrifuged at 21,000 g for 30 min and the precipitate was
collected and dispersed in CHCl3 at a concentration of 1 mgmL−1.
Ultrafast laser irradiation. For ultrafast laser irradiation, we used a Ti:Sapphire
amplified (Spitfire from Spectra-Physics) pumped by a Ti:Sapphire oscillator
(Tsunami from Spectra-Physics) both operating at 808 nm. The amplifier provides
pulses with a repetition rate of 1 kHz and tunable pulse widths in the 50–550 fs
range by fine adjustement of the compensating gratings. The average power was
controlled by using a set of polarizers and a λ/2 waveplate (AQWP10M-980 from
Thorlabs). A 45 cm focal length lens was used to focus the irradiation beam into a
hermetically closed quartz cuvette containing the dispersion of Ag2S dots in CHCl3.
The Ag2S concentration was set to 1 mgmL−1 in all experiments. The focusing lens
was mounted on a translation stage that allowed changing the lens-to-cuvette
distance and, hence, the laser spot size in the solution. This, in turn, allowed us to
change the laser power density while keeping the average laser power constant.
Supplementary Fig. 24 shows, as a representative example, the laser spot size and
the corresponding irradiation density as a function of the lens-to-cuvette distance
for a fixed irradiation laser power of 0.6W. The NIR-II emission was continuously
registered during the irradiation process by a fiber-coupled spectrometer with
enhanced sensitivity in the 900–1700 nm spectral range (Ocean Optics NIR-
QUEST212). Real-time temperature measurements during irradiation were per-
formed by means of a thermocouple placed into the solution. The distance between
the thermocouple and the laser focal spot was set to 2 mm in order to avoid direct
heating of the thermocouple by the 808 nm laser beam.
Synthesis and characterization of Ag-NP-free Ag2S dots (neat Ag2S dots).
The synthesis of the Ag-NP-free Ag2S dots was carried out by thermal decom-
position of the precursor silver diethyldithiocarbamate (AgDDTC). The precursor
was synthesized as follows: 0.025 mol of AgNO3 were dissolved in 200 mL of
bidistilled water produced from Milli-Q water. Later 0.025 mol of DDTC (die-
thyldithiocarbamate) were dissolved in 300 mL of bidistilled water and added to the
above solution. The resulting yellow powder was filtered and dried at 60 in vacuum
using a rotary evaporator. After that, 25 mg of AgDDTC was dispersed in 5 mL of
1-dodecanethiol and the mixture was stirred under vacuum for 30 min. After that,
the solution was heated up to 200 °C for 1 h. After this time, the solution was
cooled down naturally. When the temperature of the mixture reached 25 °C, 10 mL
of ethanol was added and the solution was centrifuged at 10,000 rpm for 10 min.
The supernatant was discarded and the precipitate collected in 10 mL of CHCl3.
Ligand exchange procedure. To use the Ag2S superdots for in vivo imaging, we
transferred them from CHCl3 to water by a ligand exchange reaction between the
octadecylamine and HS-PEG-COOH (Mw of 2100 g mol−1). 2 mg of Ag2S
superdots dispersed in 1 mL of CHCl3 were mixed with 1 mg of HS-PEG-COOH
and sonicated for 5 min to facilitate the ligand exchange. Afterwards, the CHCl3
was gently evaporated until reaching a total volume of 500 μL. Then, 500 μL of
absolute ethanol were added and the dispersion was sonicated for 5 min. This
process was repeated four additional times in order to ensure the maximum
removal of CHCl3. The Ag2S superdots dispersed in 1 mL of absolute ethanol were
then concentrated to a volume of 100 μL and transferred dropwise to 900 μL of
PBS, prepared by dissolving a tablet in 100 mL of Milli-Q water.
Scanning transmission electron microscopy (STEM). For the STEM studies, a
JEOL ARM200 cF was used. This microscope is equipped with a Cs corrector in the
condenser lens and an OXFORD INCA detector of 100 mm² for XEDS analysis.
The experiments were carried out at 80 kV as the sample was beam sensitive to
higher acceleration voltages. As a first step, sample stability was carefully checked
in function of the different parameters of the microscope. To get the highest
possible intensity in the XEDS detector without damaging the sample, we deter-
mined that the optimum conditions were achieved by using a condenser lens
aperture of 50 micrometers and a spot size of 6. In these conditions, the probe
current is well above 120 pA. The camera length for the STEM images was set to 6
cm so that the collection angles range from 90 to 370 mrad.
Dynamic light scattering (DLS) and Z-potential determination. The DLS and Z-
potential measurements were performed using a Zetasizer Nano ZS instrument
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(Malvern Instruments, U.K.). The accumulation time was determined auto-
matically for each sample. The sample concentration was adjusted to obtain 3000
cps. The acquired data were processed using the software provided by Malvern
(Zetasizer software v7.03).
Quantum yield measurements. The absolute photoluminescence QY was mea-
sured with a calibrated spectrofluorometer (Edinburgh Instruments, FLS920)
equipped with an integrating sphere (Jobin-Yvon). A Xe lamp was used as the
excitation source, filtered with a longpass filter (610 nm) and a monochromator
(wavelength: 808 nm, bandwidth: 20 nm), and a liquid-nitrogen-cooled NIR pho-
tomultiplier tube (Hamamatsu, R5509-72) was used for detection. The QY was
calculated by dividing the total number of emitted photons in the 900–1700 nm
range by the total number of absorbed photons at 808 nm. A representative
example of the excitation and emission spectra used for the determination of the
QY is shown in Supplementary Fig. 7.
Luminescence decay curves. Luminescence decay curves were obtained by
exciting the samples with an OPO oscillator pumped by a frequency doubled Nd:
YAG laser (Lotis), which provides 8 ns pulses at a repetition rate of 10 Hz. The
fluorescence intensity was detected with a Peltier-cooled photomultiplier tube with
enhanced sensitivity in the NIR-II (Hamamatsu R5509-73). The contribution of
scattered laser radiation was removed with two longpass filters (Thorlabs FEL850)
and a high brightness monochromator (Andor Shamrock 320). The time evolution
of the fluorescence signal was recorded and averaged by a digital oscilloscope (Le
Croy Waverunner 6000).
In vivo imaging. NIR-II in vivo images were obtained in a custom-made NIR-II
imaging system. A fiber-coupled diode laser operating at 808 nm was used as
excitation source (LIMO30-F200-DL808). The illumination power density was
controlled by adjusting the diode current. The anesthetized mouse was placed on a
temperature-controlled plate set to 36 °C. The NIR-II fluorescence images were
acquired with a Peltier-cooled InGaAs camera (Xenics Xeva 320) cooled down to
−40 °C. Two longpass filters (Thorlabs FEL850) were used to remove the back-
ground signal generated by the scattered laser radiation. In addition, in vivo images
were acquired using an additional 1100 nm longpass filter to ascertain the effect of
further spectral filtering on the spatial resolution of the NIR-II images (see Sup-
plementary Figs. 25 and 26).
In vivo experiments were approved by the regional authority for animal
experimentation of Comunidad de Madrid and were conducted in agreement with
the Universidad Autónoma de Madrid (UAM) Ethics Committee, in compliance
with the European Union directives 63/2010UE and Spanish regulation RD 53/
2013. Experiments were designed in order to use the minimal amount of animals,
in accordance with the 3Rs ethical principle. No randomization or blind studies
were performed. For this study, 15 CD1 female mice (8–14 weeks old, weighing
25–39 g) bred at the animal facility at UAM were used. Mice were anesthetized
prior to the imaging experiments in an induction chamber with a continuous flow
of 4% isoflurane (Forane, AbbVie Spain, S.L.U) in 100% oxygen until loss of
righting reflex was confirmed and breathing rhythm was significantly slowed.
Anesthesia was maintained throughout the experiments by means of facemask
inhalation of 1.5% isoflurane and core body temperature was kept at 36 ± 1 °C, as
measured with a rectal probe, using a heating pad.
To study the performance of Ag2S superdots as contrast agents in bioimaging
when compared to other NIR-II probes, four mice were shaven and subcutaneously
injected with 100 μL of a 1.5 mg mL−1 NP (Ag2S superdots, Ag2S dots, LaF3:Nd3+
or SWNTs) dispersion in PBS.
To study the biodistribution of the Ag2S superdots, two additional mice
received a small incision in the neck skin to expose the right jugular vein. A
polyethylene tubing catheter was inserted 2 mm in the caudal direction to infuse
100 μL of solution containing 1.5 mg mL−1 PEG-coated Ag2S superdots dispersed
in PBS. Three hours after infusion, mice were euthanized by isoflurane overdose
and organs (liver, spleen, heart, and lungs) were collected to obtain ex vivo NIR-II
images.
One additional mouse was anesthetized in order to check the laser-induced
thermal loading with and without fur. In this case, the temperature at the skin
surface was measured with an infrared thermographic camera (Fluke iT10).
In vivo biocompatibility studies. Four additional mice were intraperitoneally
injected with 300 μL of a 500 μg mL−1 solution of Ag2S superdots in PBS. Four
mice intraperitoneally injected with 300 μL of PBS were used as control group. The
animals were housed in two separated cages in a room (23 ± 2 °C) maintained on a
12/12 h light/dark cycle with free access to food and water. Weight, food intake,
and surface temperature, as measured by an infrared thermographic camera (FLIR
E-40), were analysed in the awake mice on a daily basis for 2 weeks.
In vivo subchronic toxicological studies. Fifteen mice were intravenously injected
with 100 μL of a 0.15 mgmL−1 dispersion of Ag2S superdots and euthanized in
groups of three at 24 h, 7, 14, 21, and 28 days post injection. Two additional groups
(n= 2) were injected with PBS and euthanized after 24 h and 28 days. Serum ALT-
Alanine transaminase, ALP-Alkaline phosphatase, AST-Aspartate transaminase,
creatinine, and total bilirubin were determined.
In vitro cytotoxicity experiments. Cytotoxicity of Ag2S nanodots was evaluated in
HeLa (human cervical adenocarcinoma), NIH-3T3 (swiss mouse embryo fibroblasts)
and IMR-90 (human lung fibroblasts) using the thiazolyl blue tetrazolium bromide
(3-(4,5-dimethyl-thiazol-2yl)−2,5-diphenyltetrazolium bromide, MTT) assay.
Briefly, cells in complete medium (DMEM with 10% FCS, 1 mM pyruvate, 2 mM
glutamine, 100 UmL−1 penicillin, 100 μgmL−1 streptomycin, and 50 μgmL−1
gentamicin) were seeded in 96-well culture plates at a density of 104 cells per well.
After 24 h of incubation (37 °C, 5% CO2). Cells have been tested for mycoplasma
contamination. Ag2S nanodots were added to cells at different concentrations up to
200 μgmL−1 and further incubated for 48 h. Then, MTT solution was added for 4 h
to the plate and afterwards, MTT reaction was stopped by adding a solution of
dimethylformamide-SDS. Finally, the plate was gently shaken for 2 h to dissolve
formazan crystals prior to measure 570/590 nm absorbance in an Appliskan
(Thermo Scientific) plate reader. Corrected absorbance was transformed to per-
centage of cell viability using the following formula:
%Cell viability ¼ Abs sample
Abs control
´ 100;
where Abs is the corrected absorbance at 570 nm after subtracting the absorbance at
590 nm.
Experiments were carried out four times and data were represented as a mean ±
standard error.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Source data for all figures are available with the paper. All other data generated and
analysed from this study are available from the corresponding authors upon reasonable
request.
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